The majority of data that contribute to our understanding of mammalian embryonic development This article reviews the results of investigations that have examined splotch locus mutants. These studies include histological analyses at the structural and ultrastructural levels, gene-teratogen interactions, as well as outcomes from immunohistochemical, biochemical, cellular, and molecular approaches. Information gathered from the analyses of these mutants has contributed to our understanding of neurulation and neural crest cell emigration, and has provided clues as to how these two fundamental processes may be developmentally related. Early linkage analysis showed Sp belonged to linkage group XIII and was positioned between the coat colour mutation leaden (In) and the hair follicle mutation fuzzy (fz).910 Recombination frequencies between Spd and either In orfz were found to be similar to those of Sp,7 supporting the idea that Spd was indeed allelic to Sp. Since then, the splotch locus has been mapped more specifically to band C4 of chromosome 111 and investigations to define this locus further using DNA probes are currently in progress.
The majority of data that contribute to our understanding of mammalian embryonic development are obtained from the study of animal models. An increasing availability of molecular tools to dissect these model systems has enabled us to establish parallels with human development that range from morphogenetic similarities to homologous DNA sequences. The mouse mutant splotch (Sp) has long been recognised as a model for human neural tube defects (NTDs) and, more recently, has become a candidate model for Waardenburg syndrome type I (WSI) in humans."2 This latter circumstance is based on similarities in some of the defects in neural crest cell (NCC) derivatives that are shared by Sp mutants and Waardenburg patients, as well as the possibility that WSI may be localised to human chromosome 2q37, a region known to share homologies with mouse chromosome 1 where the Sp locus is found.
Neurulation occurs between gestation day and late day 9 in the mouse (plug day= day 0) and this is comparable to days 20 to 26 of human embryonic development.3 Neural crest cells originate from the neural tube and begin to emigrate just before cephalic neural tube closure, or shortly after trunk neurulation in mammalian embryos. Thus, the two events occur almost simultaneously in development. NCCs then migrate to various regions of the body and differentiate into a variety of structures including neuronal cells of the sensory and autonomic ganglia, nerve supporting structures, mesoectodermal structures, certain cells of the endocrine system, and melanocytes. 45 The fact that both neurulation and NCC emigration are disrupted in the Sp mutant makes this a useful model for understanding the basis of two fundamental developmental processes.
This article reviews the results of investigations that have examined splotch locus mutants. These studies include histological analyses at the structural and ultrastructural levels, gene-teratogen interactions, as well as outcomes from immunohistochemical, biochemical, cellular, and molecular approaches. Information gathered from the analyses of these mutants has contributed to our understanding of neurulation and neural crest cell emigration, and has provided clues as to how these two fundamental processes may be developmentally related. 26 27- mutant, is a recessive mutation with incomplete penetrance that has yet to be assigned to a particular chromosome. This, in addition to the fact that only about 60% of all curly-tail embryos develop an NTD, makes it difficult to carry out investigations on abnormal neural tube closure until the development of an NTD is well under way.
In the case of Sp, however, only the skull and vertebral malformations that are associated with an open neural tube are present in conjunction with the defects in certain NCC derivatives, which also originate from the neural tube. Therefore, it is possible that a mechanism directly involved in neurulation is the primary target of the Sp mutation. This, combined with the fact that Sp mutants can be identified before the manifestation of an NTD,1928 Dyke29 attributed this to an increase in mitotic activity between 13-5 and 14 5 days of gestation. Using tritiated thymidine incorporation, Wilson30 showed that mesencephalic cells of day 10 and 1 1 Sp embryos undergo a longer cell cycle than that found in heterozygous or wild type embryos, and that proliferation is actually decreased in these mutants. However, through analysis of even younger embryos, Kapron-Bras and Trasler3' found that the mitotic index was similar between all regions of day 9 Sp and control embryos. Thus, any difference in the mitotic index between mutants and non-mutants probably reflects secondary changes following the initial disruption of neural tube closure.
Other Although Sp mutants can be identified by either skin grafts or the length of their neuropores relative to non-mutant embryos at the same developmental stage, it is not possible to distinguish between heterozygous and wild type embryos by these methods. Thus, it was necessary to develop a more specific marker.
Kapron-Bras et at42 devised a breeding scheme that introduced a 1.3 Robertsonian translocation (a fusion of chromosomes 1 and 3) into the Sp line. This could then be used as a marker for the chromosome carrying the wild type allele. However, using this system to predict the genotype provided 80% reliability in heterozygotes, but only 60% accuracy in homozygotes owing to cross over. Therefore, a more dependable genotyping strategy was required. 
Splotch extracellular matrix components
According to histological observations,3' the closed neural tube in the trunk region of Sp/Sp embryos is in close apposition to the overlying ectoderm, and, unlike control sections, has very little extracellular space between the two tissues. Because fewer NCCs were observed in these regions compared to controls, it was suggested that the lack of extracellular space could be due to alterations in extracellular matrix components and that this, in turn, may inhibit NCC emigration from the neural tube.
Several immunohistochemical and ultrastructural analyses have focused on the temporal and spatial localisation of specific extracellular matrix constituents in Sp and Spd mutants. Using late day 9 or day 11 Spd embryos that exhibited the mutant phenotype, O'Shea and Liu55 found that the basal lamina of the neuroepithelium was disorganised, and that there was less laminin and collagen IV, and more fibronectin and heparan sulphate proteoglycan (HSPG) in the dorsolateral region of the neural tube compared to controls. Fibronectin and HSPG were also found to be displaced in the mutants during secondary neurulation. McLone and Knepper56 also observed alterations in certain glycoconjugates and glycosaminoglycans in day 10 Sp mutants. Using enzymatic digestion to quantitate particular extracellular matrix components, these authors reported that the distribution of hyaluronic acid (HA) and chondroitin sulphate (CSPG) was approximately equal in mutant neuroepithelium, whereas in normal embryos HA is predominant in the open neural tube and CSPG is predominant in the closed neural tube. McLone and Knepper56 also found differences in lectin staining patterns between Sp mutants and controls, with a persistent and intense concanavalin-A staining on the abnormal luminal surface.
Other studies have examined Sp and Spd mutant embryos at slightly earlier stages of development in order to assess extracellular matrix aspects before the abnormal phenotype is apparent. These embryos were identified as mutant by the In (1) Yang and Trasler58 observed that the basal lamina of the overlying surface ectoderm was not as well formed as that of controls, that there were fewer mesodermal cells in mutant embryos, and that the neuroepithelium was disorganised and contained a greater amount of intercellular space. This latter observation corroborated similar findings in slightly older Sp mutants.34 Furthermore, it showed that these morphogenetic differences were present even before the defects become apparent, suggesting that one of the primary effects of the mutant gene is to elicit these changes in the neuroepithelium. In contrast, Yang and Trasler58 did not observe the significant differences in gap junctional vesicle formation between Spd mutants and controls that were reported by Wilson and Kapron-Bras and Trasler3' have shown that few NCCs are released from mutant neural tubes. However, it was unclear as to whether this occurred as a result of an abnormality in the neuroepithelium, the ECM into which NCCs emigrate, or whether the NCCs themselves were at fault. Examination of NCC emigration from explanted neural tubes28 showed that there was approximately a 24 hour delay in the release of NCCs from mutant neural tubes compared to non-mutants, with Sp being more severely affected than Spd. Provision of an enriched three dimensional extracellular matrix containing laminin, collagen IV, HSPG, and entactin failed to enhance NCC release significantly, and assessment of mitotic indices showed no difference in NCC proliferation between mutant and non-mutant genotypes. Therefore, these findings indicated that the neuroepithelium from which NCCs arise may be faulty in the Sp mutant with respect to the mechanism involved in the release of NCCs.28
Cell adhesion molecules (CAMs) in splotch Since specific cell adhesion molecules are known to be involved in neural development, it is of interest to examine some of these with respect to Sp. Using immunofluorescent techniques, Moase 
